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The NADPH oxidase Nox2, a multi-subunit enzyme complex comprising membrane and cytosolic pro-
teins, catalyzes a very intense production of superoxide ions O2 , which are transformed into other
reactive oxygen species (ROS). In vitro, it has to be activated by addition of amphiphiles like arachidonic
acid (AA). It has been shown that the membrane part of phagocyte NADPH oxidase is present in lipid rafts
rich in cholesterol. Cholesterol plays a signiﬁcant role in the development of cardio-vascular diseases that
are always accompanied by oxidative stress. Our aim was to investigate the inﬂuence of cholesterol on
the activation process of NADPH oxidase. Our results clearly show that, in a cell-free system, cholesterol
is not an efﬁcient activator of NADPH oxidase like arachidonic acid (AA), however it triggers a basal low
superoxide production at concentrations similar to what found in neutrophile. A higher concentration, if
present during the assembly process of the enzyme, has an inhibitory role on the production of O2
 .
Added cholesterol acts on both cytosolic and membrane components, leading to imperfect assembly and
decreasing the afﬁnity of cytosolic subunits to the membrane ones. Added to the cytosolic proteins, it
retains their conformations but still allows some conformational change induced by AA addition, in-
dispensable to activation of NADPH oxidase.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Introduction
The damaging role of reactive oxygen species (ROS) in cardio-
vascular diseases (atherosclerosis, vascular inﬂammation, and
endothelial dysfunction) leading to coronary heart disease, stroke
or angina pectoris has been known for some decades. NADPH
oxidase Nox2 is one of the major actors at the origin of oxidative
stress. Actually Nox2 is one of the main isomers involved in the
cardiovascular ﬁeld [1]. On the other hand, high cholesterol level is
linked to an elevated risk of cardiovascular disease [2], through
high concentration of LDL-cholesterol in blood [3,4]. High cho-
lesterol has also been associated with diabetes and high bloodB.V. This is an open access article u
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e-Levin).pressure [5,6]. Interestingly, NADPH oxidases have been found in
lipid rafts (LR), which are dynamic, detergent-resistant plasma
membrane microdomains highly enriched in cholesterol and
sphingolipids [7,8]. Cytoplasmic proteins are efﬁciently recruited
to these raft-associated ﬂavocytochrome b558 upon activation to
reconstitute the active complex [9]. Moreover, distribution and
regulation of NADPH oxidase by LRs were reported in murine
microglial cells and bovine aortic endothelial and coronary arterial
endothelial cells [10–14]. These facts prompted us to study the
effect of cholesterol on the functioning of NADPH oxidase. In this
paper, we investigated the consequences of the presence of cho-
lesterol on the production of reactive oxygen species.
The NADPH oxidase catalyzes the formation of superoxide an-
ion (O2) by a single-electron reduction of the molecular oxygen
using NADPH as the electron donor [15–17]. O2 is considered to
be the starting point for the generation of a vast assortment of
reactive oxidants since it is subsequently transformed into hy-
drogen peroxide, hypochlorous acid, hydroxyl radical and perox-
ynitrite [18,19]. Deregulation of NADPH-oxidase activity is linked
with a large panel of pathologies in addition to cardiovascular
ones, involving inﬂammatory processes, renal damage, central
nervous system diseases, immune system disorders, induction of
apoptosis after irradiation by low doses of ionizing radiations etc.,
[20–31].nder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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membrane-bound ﬂavocytochrome b558 (Cyt b558), comprising
two subunits (Nox2 also known as gp91phox, and p22phox) and four
cytosolic components. Nox2 harbors the redox carriers (bound FAD
and two hemes) and the NADPH binding site. The cytosolic com-
ponents include p47phox, p67phox, p40phox, and a small GTPase
Rac1 or Rac2 [32]. Because of the high toxicity of the reactive
oxygen species (ROS), the NADPH-oxidase activity is tightly
regulated spatially and temporally. In resting phagocytes, the
components of the complex exist as separated entities but upon
cell activation by pro-inﬂammatory mediators, the cytosolic
subunits undergo posttranslational modiﬁcations such as phos-
phorylation [33,34] and migrate to the membrane bound Cyt
b558 to constitute the activated NADPH–oxidase complex [35].
Actually this process involves a complicated set of protein–protein
and protein–lipid interactions to conduct to oxidase assembly
[36–39].
Studies on binding between the different soluble subunits
p47phox, p67phox, p40phox performed in vitro suggested that these
three cytosolic subunits are preassembled [40–42]. Recently, dif-
ferent constructions of chimeras were designed, in which in-
dividual cytosolic subunits were fused [p47phox–p67phox] [43] or
[p67phox–Rac1] [44–48] and supplemented by the missing third
subunit (Rac1 and p47phox, respectively). Another strategy was to
construct a trimera which consisted of the following domains [p47
phox (aa 1–286), p67phox (aa 1–212) and a full length Rac1 (aa
1–192)] in which interactions among cytosolic subunits were
replaced by fusion. This trimera was found to act as potent am-
phiphile-dependent oxidase protein activator upon assembly to
native phagocyte membrane or puriﬁed Cyt b558[49]. The sub-
sequent change from this construction was performed by adding
isoprenyl group to the C-terminus of Rac1 part, mimicking in vivo
reality, where Rac is found exclusively in the prenylated form.
Further modiﬁcation was the introduction of Q61L mutation in the
Rac part of the trimera, making Rac constitutively in the GTP-
bound form. It ensures that in the trimera an intramolecular bond
was built between Rac1 and p67phox which is essential for oxidase
activity ability of trimera [50,51].
The development of a cell-free oxidase activation system was a
great help in the understanding of the mechanism of NADPH
oxidase activation. This system was designed to mimic in vivo
oxidase activity under in vitro conditions. In cell-free systems, the
activation process is bypassed by the introduction of an activator,
an anionic amphiphile such as arachidonic or other fatty acids or
surfactants [52–57]. We took advantage of this system, which
permits strict quantiﬁcation of the components of interest, and
modiﬁcations of membrane composition. In addition, for simpli-
city, we have replaced the cytosolic subunits by the trimera
[49,50]. A precondition for using the trimera was to ascertain that
it is functionally comparable with the separated cytosolic subunits.
We have veriﬁed that the rates of production of superoxide anions
were similar (supplementary material) and that the dependences
of the activity in function of AA concentration were also compar-
able with the cytosolic fractions and the trimera [58]. In addition,
the presence of two states in the activation process, a sensitive one
followed by a resistant one against ROS damages, observed with
the separated cytosolic subunits [59] was also found with the
trimera (data not shown). Consequently, we have chosen the tri-
mera instead of the separated subunits in order to diminish the
number of independent parameters to consider and to facilitate
the interpretation.Material and methods
Materials
Equine heart cytochrome c (cyt c), arachidonic acid (cis-AA),
phenylmethanesulfonyl ﬂuoride (PMSF), isopropylthiogalatoside
(IPTG), cholesterol, Dulbecco PBS and methyl-β-cyclodextrin
(MβCD) were from Sigma (Saint-Quentin Fallavier, France). Re-
duced β-nicotinamide adenine dinucleotide phosphate (NADPH)
was from Acros. Ni-sepharose, superdex 75 and Ficoll-Paque Plus
was from GE Healthcare, France.
Neutrophil membrane preparation
The neutrophils were prepared from human blood from heal-
thy donors (ESF, Paris, France) as described in [60]. Brieﬂy, 500 mL
of blood was sedimented in 2% dextran solution for 40 min. PBS
was added to the pellets, and then the neutrophils were separated
from lymphocytes and the red cells by centrifugation for 30 min at
400g on Ficoll. The red cells were further eliminated after their
lysis by centrifugation for 8 min, 400g, 4 °C. The pellet re-
suspended in PBS pH 7.4 containing 340 mM sucrose, 7 mM
magnesium sulfate, 1 mM PMSF, 0.5 mM leupeptin was sonicated
in the 30% pulse mode at power pulses (6) in an ice-cooled beaker
6 times during 10 s with interval of 1 min between the sonications
(sonicator XL, Misonix Inc.). Neutrophil membranes and cytosol
were separated by centrifugation for 1 h 30 min at 200,000g at
4 °C. The membrane fractions were resolubilized, aliquoted and
stored at 80 °C for further experiments.
Expression of the trimera
The plasmid of the trimera was a generous gift from Prof. E.
Pick. Trimera (p47phox aa 1–286, p67phox aa 1–212, and RacQ61L
full length) was expressed and isolated from Escherichia coli BL21-
DE3-plys. A stock culture of E. coli (glycerated, stored at 80 °C)
expressing the trimera was used to inoculate a Petri dish of Luria
Bertani (LB) agar, supplemented with kanamycin and chlor-
amphenicol and incubated at 37 °C for 16 h. A colony was then
cultured in 60 mL of LB medium supplemented with 50 mg/L of
kanamycin and 34 mg/L of chloramphenicol, incubated at 37 °C for
about 16 h. 20 mL of this culture were added to 1.5 L of Terriﬁc
Broth medium (TB) supplemented with 50 mg/L of kanamycin and
34 mg/L of chloramphenicol. The ﬂask was incubated in shaking
condition at 37 °C until it reached an absorbance of 0.9 at 600 nm,
then 0.5 mM IPTG were added to induce the synthesis of protein
and the culture was incubated overnight at 30 °C. The culture was
pelleted and placed in the freezer at 20 °C until use.
Extraction of the trimera from bacteria
The bacterial pellet, containing the trimera obtained previously,
was dissolved in a buffer containing 50 mM HEPES (pH 7.5),
200 mM NaCl and 1 mM EDTA to which was added 1 mg of DNase,
1 mM PMSF, 1 mM DTT and 1 mM benzamidine. The bacteria were
sonicated during 4 times 2 min in a 50% pulse mood at power
pulses (6) in an ice-cooled beaker with pauses of 2 min. The bac-
terial lysate was centrifuged at 160,000g for 1 h 30 min at 6 °C. The
cleared cell-free supernatant was ﬁltered to remove all traces of
debris and bacteria.
Puriﬁcation of the trimera
The trimera was expressed as fusion protein. Thus it was pur-
iﬁed by metal chelate afﬁnity chromatography. The above super-
natant was applied to nickel afﬁnity column after being diluted
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and 1 mM PMSF, pH 7.4). The mixture was loaded for 1 h 30 min so
that the proteins of interest effectively cling to the nickel resin.
Then the column was washed with the same buffer to remove
unwanted bound proteins. The proteins bound to the beads were
eluted from the resin with elution buffer (0.1 M NaCl, 30 mM
Na2HPO4 and 300 mM imidazole, pH 7.4). Then size exclusion
chromatography was carried out to better purify the trimera.
Proteins concentration was determined using a NanoDrop2000
spectrophotometer (Thermo scientiﬁc, France) and the extinction
coefﬁcient of 1.5 mg1/mL cm. The purities of all proteins were
checked by migration on 10% BisTris-NuPAGE SDS gels (Invitro-
gen), stained with Coomassie Brilliant Blue (Fig. S1 in Supple-
mentary material).
Dialysis and storage of the trimera
Trimera fractions were pooled in a dialysis tube whose mem-
brane was of 10 kDa porosity. The tube was placed in 2 L dialysis
buffer (100 mM NaCl and 30 mM Na2HPO4, pH 7.5) at 4 °C over-
night. The dialyzate was recovered and trimera was stored at
80 °C.
Quantiﬁcation of intrinsic cholesterol
Intrinsic cholesterol concentration in human neutrophil mem-
brane fractions was measured by the Amplex Red Cholesterol
Assay Kit purchased from Invitrogen [61,62]. The intrinsic cho-
lesterol concentration was estimated by three independent mea-
surements on different blood donors.
Depletion of cholesterol from neutrophil membrane
Methyl-β-cyclodextrin (MβCD) is a well established cholesterol
depleting reagent of phospholipidic membrane without affecting
their permeability and it is the most commonly used reagent [63–66].
The neutrophil membranes were incubated for 1 h, at 4 °C, in
presence of 10 mM MβCD. The mixture was centrifuged at
148,000g for 1 h 30 min at 4 °C. Neutrophil membranes were
found in the pellet and the cyclodextrin–cholesterol complexes
were in the supernatant. The neutrophil membranes were re-
solubilized in PBS.
Measurement of superoxide production in cell-free assays
Superoxide anion production rates were quantiﬁed by the in-
itial rate of cytochrome c (Cytc) reduction, as described before
[67]. The reaction is as follows:
Cyt cox þ O2 - O2 þ Cyt cred
Unless indicated, the components of the cell-free system were
added as follows: (2–5 nM Cyt b558) membrane fractions, (100–
200 nM) trimera and (40 mM) arachidonic acid in 500 mL Phos-
phate Buffer Saline supplemented with 10 mM MgSO4 for 4 min of
incubation at 25 °C in order to allow the Nox complex assembly.
The production was initiated by addition of (250 mM) NADPH and
the rate of O2 was quantiﬁed by the reduction of cytochrome c
(50 mM). The rate was measured at 550 nm in a Thermo evolu-
tion500 Spectrophotometer. The amount of superoxide was cal-
culated using a molar extinction coefﬁcient (Δε of the reduced
minus oxidized form of Cytc) of 21 mM1 cm1. 20 mM stock
solution of cholesterol was prepared in ethanol. Further dilutions
have been done in ethanol to get a concentration range of cho-
lesterol (0.1–16 mM), which was mixed with AA 65 mM. 3 mL of
each mixture was introduced in the cell free system to ﬁnally havecholesterol 0.25–40 mM in a mixture with 40 mM AA in the ﬁnal
reaction volume. This allowed keeping the volume constant.
2.10. Determination of enzymatic parameters and curve plotting
The enzymatic parameters EC50 and Vmax were calculated by
non-linear least square ﬁtting of the curves of superoxide rate of
production vs. protein concentration using the following expres-
sion.
=
+
v
v P
P
[ ]
EC [ ] (1)
max
50
where [P] is the concentration of the considered protein (trimera).
Plotting and calculation were performed using Graph Pad Prism
Version 6.
Intrinsic ﬂuorescence assays
Steady-state ﬂuorescence spectra were performed on a Photon
Technology International scanning ﬂuorimeter at 25 °C. Various
concentrations of AA and/or cholesterol were added as indicated
to a ﬁnal volume of 3 mL of buffer (phosphate buffer saline sup-
plemented with 10 mM MgSO4) containing trimera (60 nM) in a
quartz cuvette. The tryptophan ﬂuorescence spectra of trimera
were obtained by exciting the samples at 290 nm (2 nm band-
width) and recorded between 300 and 400 nm (5 nm bandwidth).
The excitation wavelength was chosen at 290 nm to optimize the
signal to noise ratio and to reduce the contribution of tyrosine
residues to the signal [68].Results
Intrinsic cholesterol concentration and effect of cholesterol depletion
by methyl-β-cyclodextrin on superoxide production rate
We ﬁrst measured the intrinsic cholesterol concentration in
human neutrophil membrane fractions. We found 371 mM cho-
lesterol in the ﬁnal reaction volume of cell free system assay (2 nM
Cyt b558, 40 mg/mL membrane proteins) in three independent
measurements. Then to investigate the role of cholesterol that is
naturally present in the neutrophil membrane on NADPH oxidase,
10 mM MβCD was used to disrupt lipid rafts by removing choles-
terol from membranes [66,69,70]. The rate was measured as de-
scribed in Material and methods. We found that cholesterol de-
pletion decreased superoxide production rate relative to the non-
treated membrane neutrophil to (4477)%.
In the following studies, the level of cholesterol was increased
to a range corresponding to hypercholesterolemia (up to ca. 33% of
the normal concentration) and above, to enlighten the effects of
this addition.
Cholesterol as an activating molecule?
Having established the most propitious conditions for activa-
tion (see Materials and methods), we aimed at determining
whether cholesterol could have an activator effect on NADPH
oxidase. The results expressed as percentages of NADPH oxidase
activity as a function of cholesterol are displayed in Fig. 1. Addition
of cholesterol in the range 0.2–1 mM (ca. 7–33% increase compared
to the intrinsic value) provoked slight but signiﬁcant activation of
NADPH oxidase complex, but not at an equivalent level to AA. The
rate of production of O2 stayed at around 15% of the rate value
obtained with AA for concentrations above 1 mM. Comparable re-
sults were obtained using the separated subunits where a
Fig. 1. Dependence of NADPH oxidase activity as a function of cholesterol con-
centration in the absence of arachidonic acid. Membrane fractions (2 nM Cyt b558)
with trimera 200 nM were incubated 4 min in presence of different concentrations
of cholesterol. Control experiment representing 100% (68 mol O2/s/mol Cyt b558)
of the activity was realized in presence of 40 mM AA and in absence of cholesterol.
The rates of superoxide production were measured as described in Materials and
methods. The data are the average of 3 independent measurements7SEM.
Table 1
nParameters of the ﬁts of Fig. 2. Y=Ymin+ ++ +
Y
K
Y
K
1
(1 [chol] / i1)
2
(1 [chol] / i2)
Value Error
Ymin (%) 35 9.6
Y1 (%) 30 4.6
Ki1 (mM) 0.19 0.09
Y2 (%) 35 7.3
Ki2 (mM) 21.2 16.7
R. Masoud et al. / Redox Biology 3 (2014) 16–24 19maximum activity of (2072)% of AA-dependent activity was
reached (data not shown).
Superoxide production in the presence of AA plus added cholesterol
NADPH oxidase activity was inhibited by the addition of cholesterol
Since cholesterol alone does not activate NADPH oxidase, we
have tested the cholesterol effect on activation by AA.The AA in-
duced NADPH-oxidase activity was followed upon increasing
concentrations of cholesterol (Fig. 2). To avoid an increase of sol-
vent volume, a mixture of cholesterol added with AA for each
cholesterol concentration was prepared. The rate of production
with AA alone was considered as 100%. Surprisingly, when mem-
brane fractions and trimera were incubated together with 0.25 mMFig. 2. NADPH-oxidase activity inhibition by cholesterol. Neutrophil membrane
fractions and trimera were incubated together in the presence of a mixture of
40 mM AA plus cholesterol. The oxidase activity was expressed as the percent of
activity measured in the absence of cholesterol (79 mol O2/s/mol Cyt b558) as
described in Materials and methods. The values are an average of 3 independent
measurements7SEM. Table 1 shows the kinetic parameters of the ﬁt.cholesterol and 40 mM AA, the activity dropped to about 8675%.
The AA-induced NADPH oxidase activity was thus reduced by
addition of less than 10% of the intrinsic cholesterol amount. The
decrease of the activity could be ﬁtted by a two inhibitory sites
equation (Fig. 2) and the parameters of the ﬁt are given in Table 1.
Effect of cholesterol on AA activation proﬁle
To probe the effect of cholesterol on the NADPH activation
proﬁle by AA, we performed titrations of the activity vs. AA con-
centration in the absence and in the presence of two concentra-
tions of cholesterol (0.5 and 20 mM). In this experiment cholesterol
was added at the same time as Arachidonic acid (Fig. 3).
In the presence of cholesterol, the O2 production was lower
on the full range of concentrations of AA, which conﬁrms the in-
hibitory effect of cholesterol in a concentration-dependent man-
ner. However the maximum activity was achieved with the same
AA concentration and the bell-shape curve was kept.
Modiﬁcation of kinetic parameters in the presence of added
cholesterol
The absence of effect of cholesterol on the AA activation proﬁle
described above raised the question of the mechanism by which
addition of cholesterol decreases the activity of the complex. In that
purpose, the rate of superoxide production for increasing con-
centrations of trimera with and without cholesterol was de-
termined. This dependence could always be ﬁtted using a Michae-
lis–Menten-like equation (see materials and methods) and from
each curve one could determine EC50 and Vmax values. There was a
marked loss in the oxidase activity in the presence of cholesterol for
the whole range of concentrations of trimera, with important var-
iations for both the EC50 and Vmax values (Fig. 4, Table 2). In theFig. 3. Effect of cholesterol on the AA-dependent activation proﬁle. Neutrophil
membrane fractions and trimera were incubated together in the presence of a
mixture of varying amounts of AA plus cholesterol. The cholesterol concentration
was as follow, ▲: no cholesterol; ●: 0.5 mM cholesterol; ■: 20 mM cholesterol. Oxi-
dase activities were expressed relative to the maximum activity (119712 mol
O2/s/mol Cyt b558). The rate of O2 production was achieved as described in
Materials and methods.
Fig. 4. Effect of cholesterol on the trimera dependence NADPH oxidase activity. The
assays mixtures consisted of trimera at varying concentrations (from 0 to 420 nM)
and membrane fractions of human neutrophils (3 nM Cyt b558) to which were
added ● 40 mM AA or ■ a mixture of 40 mM AA and 10 mM cholesterol. The super-
oxide formation was measured as indicated in Materials and methods. Each curve
was ﬁtted by Michaelis–Menten like equation leading to the determination of the
EC50 and Vmax values related to the trimera. The values of these kinetic parameters
in the presence of AA alone or AA plus cholesterol are in Table 2. The values are an
average of three independent measurements7SEM.
Table 2
Kinetic parameters of NADPH oxidase activation by trimera.
Assay enriched with Vmax
(mol O2
/s/mol cytb)
EC50 (nM trimera)
AA 40 mM 70.372 48.673
AA 40 mM, cholesterol 10 mM 46.676 79.8719
Fig. 6. Effect of cholesterol on AA activation of membrane fraction and trimera.
(A) AA activation of membrane fraction and trimera (1) In the control experiment,
membrane fraction and the trimera were incubated together during 4 min in the
presence of 40 mM AA. The rate obtained corresponds to the 100% value (75 mol
O2/s/mol Cyt b558). (2–4) Membrane fractions (MF) and trimera were separately
preincubated during 10 s and mixed together for 4 min as follow: (2) both were
preincubated with 40 mM AA, (3) only MF was preincubated with 40 mM AA,
(4) only the trimera were preinicubated with 40 mM AA. (5) The rate was measured
in absence of trimera. (6) The rate was measured in absence of MF. (B) Membrane
fractions (MF) and trimera were separately preincubated during 10 s and mixed
together for 4 min as follow: ■ only MF was preincubated with 40 mM AA plus
cholesterol as indicated, ▲ only the trimera was preincubated with 40 mM AA plus
cholesterol as indicated and ● both were preincubated with 40 mM AA plus cho-
lesterol. Activities in Fig. 6B were expressed as the percent of activities measured of
Fig. 6A corresponding to each state to assess the cholesterol effect only.
R. Masoud et al. / Redox Biology 3 (2014) 16–2420presence of cholesterol, the complex exhibited 1.5 times lower Vmax
value and the EC50 was 1.6 times higher than its values measured in
absence of cholesterol, which might reﬂect a decrease of afﬁnity of
trimera for the Cyt b558.
Effect of cholesterol addition during assembly phase
To examine whether cholesterol had an effect on the oxidase
assembly process, 10 mM of cholesterol were added at different
times during the 4-min phase of assembly (Fig. 5). Depending on
the time at which cholesterol was added, various levels ofFig. 5. Effect of the addition time of cholesterol on NADPH-oxidase activity.
Membrane fractions (MF), trimera, and 40 mM AA were incubated 4 min in reaction
buffer. 10 mM cholesterol were added at various times after the addition of AA.
Conditions are as described under Materials and methods. Results are expressed as
percentages of the control activity (without cholesterol addition). The values re-
present the means7SEM of three independent experiments.inhibition were noticed. O2 production was drastically lowered
to 66% of the control when cholesterol was added immediately
after all the NADPH-oxidase components. The inhibition was less
and less important (up to 100% activity) for times longer than
1 min. If cholesterol addition took place 4 min after the mixing,
the oxidase activity remained comparable to that of the control.
Both results (Figs. 4 and 5) suggest that cholesterol interferes in
the interaction between trimera and Cyt b558.
Structural effects of added cholesterol
Effect of cholesterol on soluble and membrane proteins
To evaluate the sensitivity of each component, the membrane
part and the trimera, to cholesterol, superoxide anion production
rate was measured after pre-incubation of membrane components
or trimera or both, either with AA alone (Fig. 6A) or with a mixture
of cholesterol and AA (Fig. 6B). After 10 s of separate pre-incuba-
tions of the membrane and of the trimera, both solutions were
mixed and left for a second incubation for 4 min. We chose to pre-
incubate for 10 s because a preincubation for longer time (30 s) led
R. Masoud et al. / Redox Biology 3 (2014) 16–24 21to a drastic decrease of the activity. This was also observed in the
case of separated subunits [71].
First, when both membrane fractions and trimera were pre-
incubated separately with AA, the activity was maintained to
about 95% of the observed one in standard conditions. The same
level of activity (95%) was measured when AA was incorporated
only to the membrane fractions. On the other hand, when AA was
added only to the trimera, the activity dropped to 73% (Fig. 6A).
The experiment with AA (Fig. 6A) served as control for the ones
with cholesterol. In all cases, addition of cholesterolþAA either to
the membrane or to the trimera or to both separately led to a
decreased rate of superoxide production (Fig. 6B). Incorporating
cholesterolþAA only to the membrane fractions or only to the
trimera gave comparable effect, indicating that cholesterol could
act on both partners. When cholesterol was added to both coun-
terparts, the activity drop was more important, the addition of
5 mM or more of cholesterol to both fractions led to a decrease of
the activity down to 50%. The inhibition always increased by
increasing cholesterol concentration, in agreement with the re-
sults presented Fig. 2.
Effect of AA and cholesterol on the tryptophan intrinsic ﬂuorescence
of the trimera
To probe the effect of AA and cholesterol on the trimera con-
formational state, we followed the variation of intrinsic trypto-
phan ﬂuorescence spectra upon addition of AA and/or cholesterol
(Fig. 7). Trimera contains a total of 13 tryptophan residues. It was
previously shown that addition of AA to the cytosolic subunits
p67phox and p47phox induced changes reﬂected by measurable
decrease of the intrinsic tryptophan ﬂuorescence level [68,72].
By increasing AA concentration up to 140 mM, the ﬂuorescence
yield of the trimera underwent a concentration dependent decrease
(Fig. 7A). A small blue shift up to 5 nmwas observed, consistent with a
slightly more hydrophobic tryptophan environment.
Surprisingly, the addition of cholesterol had no effect on the
ﬂuorescence yield of the trimera but a similar blue shift up to 5 nm
was detected by increasing cholesterol concentration to 50 mM
(Fig. 7B), indicating that addition of cholesterol does not induce
conformational changes in the trimera, as AA does. When cho-
lesterol was added to the trimera treated with 40 mM AA, the in-
itial quenching of 25% due to the presence of AA still was visible,
but there was no further lowering due to cholesterol (Fig. 7C). In
addition to that the same blue shift up to 5 nm was observed after
the addition of both AA and cholesterol.Fig. 7. Intrinsic ﬂuorescence of trimera treated with either AA or cholesterol or
both. The emission spectra were measured using an excitation wavelength of
290 nm as described in Materials and methods. Results are representative of at
least three independent experiments. A: trimera 60 nM, AA as stated in the ﬁgure
legend. B: trimera 60 nM, cholesterol as stated in the ﬁgure legend. C: trimera
60 nM, AA 40 mM, cholesterol as stated in the ﬁgure legend.4. Discussion
In this work we have explored the effect of added cholesterol
on the activity of the phagocyte NADPH oxidase. This study is
related to events that could happen to Nox2 following hypercho-
lesterolemia. It is also related to the hypothesis of modulation of
NADPH oxidase activity by lipid rafts rich in cholesterol. In fact,
some studies have reported the distribution and regulation of Nox
proteins and oxidase subunits in LRs, (most of the studies were
performed in non-human cells [11–14] except those in human
neutrophils) [9,73]. Given that, NADPH oxidase activation de-
mands many partners to work together, LRs can provide a useful
platform for Nox2 and its subunits to aggregate and then function
as an active enzyme complex that produces O 2[13,14,74–78]. In
particular, it has been demonstrated that NADPH oxidase was as-
sembled and activated in LR of neutrophils, producing O2 ,
causing respiratory bursts and killing bacteria [9]. The integrity of
LRs would play a crucial role in the regulation of NADPH oxidase
activity and cholesterol would be an essential component in LRs
for NADPH oxidase in agreement with previous reports [11,79].Actually, the role of speciﬁc protein–lipid interactions in oxidase
assembly has been studied in the last decades [32,36,38]. It has
been shown that the interaction of the PX domains of p40phox and
R. Masoud et al. / Redox Biology 3 (2014) 16–2422p47phox with phospholipids constitutes an essential mechanism to
orchestrate the assembly of the cytoplasmic components with the
phagosomal membrane. The PX domain of p40phox interacts se-
lectively with phosphatidyl-inositol3-phosphate, (PtdIns(3)P)
[80,81], while the PX domain of p47phox preferentially recognizes
(PtdIns(3,4)P2) [80,82].
On the required cholesterol concentration in neutrophils
The regulatory role of LR was rationalized by the fact that
cholesterol exerts a stabilizing role in LRs by ﬁlling the void space
between sphingolipids and forming hydrogen bonds with them.
Thus, cholesterol depletion by MβCD would lead to the breakdown
of LRs as it suppresses the glue effect of cholesterol on sphingo-
lipids [83,84]. In addition to that, removal of raft cholesterol leads
to dissociation of most proteins from the rafts, rendering them
nonfunctional [85]. Shao et al. showed that incubation of the cells
with MβCD resulted in a loss of association of gp91phox with the LR
fractions [9] while Vilhardt et al. reported that cholesterol deple-
tion by MβCD reduced signiﬁcantly O2 production in both intact
cells and a cell-free reconstituted system and MβCD effect was
joined with a parallel reduction of the translocation of cytosolic
components to the membrane [11]. Later, Fuhler et al. further
demonstrated that treatment of neutrophils with the MβCD, ab-
rogated fMLP-induced ROS production and activation of protein
kinases ERK1/2 and B/Akt in both unprimed and primed neu-
trophils, further assisting the opinion that LR-associated NADPH
oxidase produces ROS and contributes importantly to the onset of
phagocytic respiratory bursts [86]. Our results about removal of
cholesterol by MβCD are in agreement with the preceding ﬁndings
since the oxidase activity was decreased to (4477)%.
On the effect of cholesterol
Our results indicated slight but signiﬁcant activation of NADPH
oxidase complex in cell free system by addition of cholesterol
alone at physiological concentrations (ca. 10–30% above the nor-
mal level), without AA. Conversely, addition of cholesterol in this
range has an inhibitory effect on AA activation of NADPH oxidase
activity. Similar amplitude was also observed at 37 °C (data not
shown). The effect of cholesterol did not interfere with that of AA
(same proﬁle), indicating different binding sites for both com-
pounds. Several facts indicate the presence of two independent
inhibitory binding sites. Effectively, in Fig. 2, the curve could be
ﬁtted only with a two-site inhibition equation. In addition, cho-
lesterol effect has been observed when it was preincubated either
with the membrane or with the trimera alone. When cholesterol
(0.2–10 mM) was added to one component (membrane or trimera)
(Fig. 7B) a small inhibition was observed (20%), but when both
components were preincubated with the same concentration, a
higher inhibition was measured (50%). It strengthens the idea
that cholesterol affects not only the membrane fraction but also
the cytosolic ones.
The kinetic parameters in the presence of cholesterol revealed
that Vmax for trimera is lower while EC50 is higher, which points
out a less stable and imperfect assembly of the complex. Fur-
thermore, cholesterol acts before assembly (Fig. 5), which might
reﬂect that, one of the cholesterol binding sites is in the interac-
tion region between membrane and cytosolic components, in the
region hindered after assembly. Indeed, once the complex is
formed, cholesterol cannot have access to it and makes no in-
hibitory effect. This effect has to be related to the observation that
the depletion of cholesterol by MβCD also reduced the transloca-
tion of cytosolic proteins [10]. The cholesterol concentration found
in membrane neutrophil seems to be optimal for NADPH oxidase
activity.4.3. On the conformation of the cytosolic partner
We have shown recently that AA modiﬁed the environment of
tryptophan residues in the separated cytosolic subunits: both p47
phox and p67phox underwent ﬂuorescence decrease, which would
be related to structural modiﬁcations necessary for their interac-
tion with Cyt b558[58,68]. A similar tryptophan ﬂuorescence de-
crease was observed for the trimera upon addition of AA. No
comparable effect of cholesterol on the trimera was observed, in-
dicating that cholesterol cannot adapt the protein to the mem-
brane subunit.
In conclusion, while the presence of cholesterol at physiological
concentration (e.g. in lipid rafts) is important for the NADPH oxi-
dase function, an increase of cholesterol amount might have sev-
eral consequences: (i) a slight but signiﬁcant activity in the ab-
sence of the usual pro-inﬂammatory signals such as AA with the
possibility of a permanent mild inﬂammatory state and (ii) an
inhibition of the activity of NADPH oxidase in the presence of pro-
inﬂammatory signals. In both cases there would be a modiﬁcation
of the response to the signaling regulation.Acknowledgments
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